Low molecular weight heparin sodium is a general term for a class of low molecular weight heparin prepared by depolymerization of ordinary heparin. Compared with heparin sodium, low molecular weight heparin sodium has the advantages of high bioavailability, strong antithrombotic effect and less bleeding adverse reactions, so it is increasingly widely used in clinical practice.

　　Indications for low molecular weight heparin sodium:

　　1, to prevent thromboembolic diseases (such as myocardial infarction, thrombophlebitis).

　　2. Treatment of thromboembolic diseases (lower extremity venous embolism, DIC).

　　3. Prevent blood clot formation during hemodialysis.

　　4. Treat unstable angina pectoris and non-Q wave myocardial infarction.

　　At present, the common low molecular weight heparin is: Enoxaparin sodium, Nardonheparin calcium, da heparin sodium and so on. Qingdao Pharmaceutical is a manufacturer of heparin sodium API. Welcome to inquire about the price of heparin sodium!